Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
Kim H, Wang D, Chalmers J, Jun M, Zoungas S, Marre M, Hamet P, Harrap S, Mancia G, Poulter NR, Cooper ME, Woodward M, Selvin E, Rebholz CM. Kim H, et al. Among authors: cooper me. J Diabetes. 2020 Dec;12(12):929-941. doi: 10.1111/1753-0407.13083. Epub 2020 Jul 27. J Diabetes. 2020. PMID: 32609422 Free PMC article. Clinical Trial.
Serum lipids and the progression of nephropathy in type 1 diabetes.
Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Cooper ME, Taskinen MR, Viberti G, Groop PH. Thomas MC, et al. Among authors: cooper me. Diabetes Care. 2006 Feb;29(2):317-22. doi: 10.2337/diacare.29.02.06.dc05-0809. Diabetes Care. 2006. PMID: 16443880 Free article.
UKPDS and the legacy effect.
Chalmers J, Cooper ME. Chalmers J, et al. Among authors: cooper me. N Engl J Med. 2008 Oct 9;359(15):1618-20. doi: 10.1056/NEJMe0807625. N Engl J Med. 2008. PMID: 18843126 No abstract available.
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
van Dieren S, Kengne AP, Chalmers J, Beulens JW, Cooper ME, Grobbee DE, Harrap S, Mancia G, Neal B, Patel A, Poulter N, van der Schouw YT, Woodward M, Zoungas S. van Dieren S, et al. Among authors: cooper me. Diabetes Res Clin Pract. 2012 Oct;98(1):83-90. doi: 10.1016/j.diabres.2012.05.002. Epub 2012 Jun 5. Diabetes Res Clin Pract. 2012. PMID: 22677192 Free article. Clinical Trial.
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon S, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S; ADVANCE Collaborative Group. Perkovic V, et al. Among authors: cooper me. Kidney Int. 2013 Mar;83(3):517-23. doi: 10.1038/ki.2012.401. Epub 2013 Jan 9. Kidney Int. 2013. PMID: 23302714 Free article. Clinical Trial.
The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
Morton J, Ng MK, Chalmers J, Woodward M, Mancia G, Poulter NR, Marre M, Cooper ME, Zoungas S; ADVANCE collaborative group. Morton J, et al. Among authors: cooper me. Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1628-33. doi: 10.1158/1055-9965.EPI-13-0149. Epub 2013 Jun 18. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23780837 Clinical Trial.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, Williams B, Chalmers J; ADVANCE Collaborative group. Zoungas S, et al. Among authors: cooper me. Diabetologia. 2014 Dec;57(12):2465-74. doi: 10.1007/s00125-014-3369-7. Epub 2014 Sep 17. Diabetologia. 2014. PMID: 25226881 Clinical Trial.
716 results